Selected Publications: Roger A. Dixon

 

Huan, T., Tran, T., Zheng, J., Sapkota, S., Camicioli, R., Dixon, R.A., & Li, L. (2018). Metabolomics analyses of saliva detect novel biomarkers of Alzheimer's disease. Journal of Alzheimer's Disease, 65(4), 1401-1416. doi:10.3233/JAD-180711

 

Han, W., Sapkota, S., Camicioli, R., Dixon, R.A., & Li, L. (2017). Profiling novel metabolic biomarkers for Parkinson’s disease using in-depth metabolomic analysis. Movement Disorders, 32(12), 1720-1728. doi: 10.1002/mds.27173

 

McDermott, K., McFall, G.P., Andrews, S., Anstey, K.J., & Dixon, R.A. (2017). Memory resilience to Alzheimer's genetic risk: Sex effects in predictor profiles. Journal of Gerontology: Psychological Sciences, 72(6), 937-946. http://dx.doi.org/10.1093/geronb/gbw161

 

Thibeau, S., McFall, G.P., Camicioli, R., & Dixon, R.A. (2017). Alzheimer's disease biomarkers interactively influence physical activity, mobility, and cognition associations in a non-demented aging population. Journal of Alzheimer's Disease, 60(1), 69-86. doi: 10.3233/JAD-170130

 

Sapkota, S., Bäckman, L., & Dixon, R.A. (2017). In non-demented aging, executive function performance and change is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle. Neurobiology of Aging, 52, 81-89. https://doi.org/10.1016/j.neurobiolaging.2016.12.022

 

McFall, G.P., Sapkota, S., McDermott, K.L., & Dixon, R.A. (2016). Risk-reducing apolipoprotein E and clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in non-demented older adults. Neurobiology of Aging, 42, 91-100. doi:10.1016/j.neurobiolaging.2016.02.032